Aicaigou LogoB2B Wiki

Phospholipid-PEG-Amine

Updated: 2026-07-21

Overview

Phospholipid Polyethylene Glycol-Amine (PL-PEG-NH2) is a synthetic hybrid molecule extensively utilized in pharmaceutical and biomedical engineering. It integrates a phospholipid anchor, a polyethylene glycol (PEG) spacer, and a terminal amine group, enabling covalent bonding with targeting ligands or therapeutic agents. The PEG component enhances solubility and reduces immunogenicity, while the phospholipid moiety facilitates integration into lipid bilayers, such as liposomes. This compound is pivotal in developing stealth liposomes, which evade the immune system for prolonged circulation. Its modular design allows customization of PEG chain length (e.g., PEG-2000, PEG-5000) and phospholipid type (e.g., DSPE, DPPC) to suit specific applications, from cancer therapeutics to diagnostic imaging.

Physical and Chemical Properties

PL-PEG-NH2 exhibits amphiphilic behavior due to its dual hydrophilic (PEG and amine) and hydrophobic (phospholipid tail) regions. The PEG chain length directly influences hydrodynamic radius and steric shielding capacity, critical for in vivo performance. The terminal amine group (pKa ~8–9) is reactive toward NHS esters, aldehydes, and other electrophiles, facilitating bioconjugation. Thermal stability is moderate, with decomposition occurring above 200°C. The compound is hygroscopic and requires anhydrous storage to prevent hydrolysis. Analytical characterization typically involves NMR, MALDI-TOF, and HPLC to confirm PEGylation efficiency and amine functionality.

Main Applications

1. **Drug Delivery**: PL-PEG-NH2 modifies liposomes to create long-circulating nanocarriers for chemotherapeutics (e.g., Doxil® analogs). The amine group enables attachment of antibodies or peptides for active targeting. 2. **Nanoparticle Functionalization**: Used to coat quantum dots or iron oxide nanoparticles, improving biocompatibility and providing conjugation sites. 3. **Tissue Engineering**: Serves as a crosslinker in hydrogel formulations or to modify scaffold surfaces for cell adhesion. In oncology, amine-reactive PL-PEG derivatives are instrumental in designing ligand-targeted therapies against tumors overexpressing specific receptors (e.g., folate, HER2).

Safety and Storage

PL-PEG-NH2 is generally low-toxicity but requires standard laboratory precautions. Avoid inhalation of powder and direct skin contact. Spills should be neutralized with absorbent materials and disposed of as chemical waste. Long-term stability is achieved at -20°C under argon, with aliquoting recommended to minimize freeze-thaw cycles. Solutions in chloroform or DMSO are stable for weeks at 4°C but should be purged with nitrogen to prevent oxidation. Degradation indicators include discoloration (yellowing) or precipitation.

B2B Procurement Guide

When sourcing PL-PEG-NH2, prioritize suppliers with ISO 13485 certification for biomedical-grade materials. Key specifications to confirm: - **PEG Molecular Weight**: Match to intended application (e.g., PEG-2000 for balance of stealth and conjugation efficiency). - **Phospholipid Purity**: ≥95% by HPLC, with low solvent residuals. - **Amine Content**: Quantified via TNBS assay or UV titration (typically 0.8–1.2 mmol/g). Bulk orders (≥100g) may qualify for 15–30% discounts. Lead times vary from 2–6 weeks for custom PEG lengths. For research use, small vials (10–50mg) are commonly available from specialty chemical distributors.

Related Manufacturers